Turmezei, Tom D. http://orcid.org/0000-0003-0365-8054
Malhotra, Karan
MacKay, James W.
Gee, Andrew H.
Treece, Graham M.
Poole, Kenneth E. S.
Welck, Matthew J.
Article History
Received: 5 December 2022
Revised: 8 March 2023
Accepted: 20 March 2023
First Online: 31 May 2023
Declarations
:
: The scientific guarantor of this publication is Tom Turmezei.
: The authors of this manuscript declare relationships with the following companies: GlaxoSmithKline, Moximed LLC, GE Healthcare, CurveBeam (now CurveBeam AI), and the Standing CT Company. TT has been a paid consultant for GlaxoSmithKline and CurveBeam.JM currently works as Global Development Medical Director (Imaging) at AstraZeneca but was not in this position at the time the study was carried out.MW is a minority shareholder for the Standing CT Company.Jamie Mackay is an editorial board member of <i>European Radiology</i> in the musculoskeletal section.
: Several of the authors have significant statistical expertise (Tom Turmezei, Graham Treece).
: As the site of imaging acquisition, the Royal National Orthopaedic Hospital, Stanmore, UK, exercised discretionary power as a public authority under the GDPR (General Data Protection Regulations) ‘public task’ Article 6(1)(e) to process information from patients with waiver of the requirements for consent or ethics approval given for this study.
: As the site of imaging acquisition, the Royal National Orthopaedic Hospital, Stanmore, UK, exercised discretionary power as a public authority under the GDPR (General Data Protection Regulations) ‘public task’ Article 6(1)(e) to process information from patients with waiver of the requirements for consent or ethics approval given for this study.
: N/A
: • Retrospective• Observational• Performed at one institution